Ascendis Pharma AS (ASND)

134.53 -2.76 (-2.01%) USD  |  NASDAQ  |  Jan 08, 14:57
More

Ascendis Pharma Cash and Short Term Investments (Quarterly): 698.64M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Novo Nordisk AS 11.22B
Evaxion Biotech AS 4.576M
Trinity Biotech PLC 2.84M
Akari Therapeutics PLC 2.246M
Cellectis SA 260.89M